Juan C. Lopez-Miralles

Intendente Jorge Palacios Avenue, 1
Murcia, MU 30003, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Purinergic Receptors as Emerging Targets in the Management of Chronic Cough: From Pathophysiology to Clinical Application.

Purinergic Receptors as Emerging Targets in the Management of Chronic Cough: From Pathophysiology to Clinical Application.

Journal: Journal of investigational allergology & clinical immunology

Published: March 05, 2026

Purinergic Receptors as Emerging Targets in the Management of Chronic Cough: From Pathophysiology to Clinical Application.

Purinergic Receptors as Emerging Targets in the Management of Chronic Cough: From Pathophysiology to Clinical Application.

Journal: Journal of investigational allergology & clinical immunology

Published: March 05, 2026

Real-life efficacy of Tezepelumab in patients with failure to other biologic drugs.

Real-life efficacy of Tezepelumab in patients with failure to other biologic drugs.

Journal: European annals of allergy and clinical immunology

Published: October 10, 2025

Expert Opinion and Evidence-Based Review on Maintenance Therapy Step-Down in Patients With Severe Asthma Controlled With Biologics.

Expert Opinion and Evidence-Based Review on Maintenance Therapy Step-Down in Patients With Severe Asthma Controlled With Biologics.

Journal: Open respiratory archives

Published: September 11, 2025

Efficacy of tezepelumab in patients with severe allergic asthma in clinical practice.

Efficacy of tezepelumab in patients with severe allergic asthma in clinical practice.

Journal: Allergologia et immunopathologia

Published: June 26, 2025

Real-life effectiveness of tezepelumab in severe asthma.

Real-life effectiveness of tezepelumab in severe asthma.

Journal: Allergologia et immunopathologia

Published: February 03, 2025

Tezepelumab in Patients With Severe Asthma: Response at 3 Months.

Tezepelumab in Patients With Severe Asthma: Response at 3 Months.

Journal: Journal of investigational allergology & clinical immunology

Published: November 25, 2024

Disease Modification in Asthma: Are We on the Right Way? A Multidisciplinary Expert Delphi Consensus (MODIASTHMA Consensus).

Disease Modification in Asthma: Are We on the Right Way? A Multidisciplinary Expert Delphi Consensus (MODIASTHMA Consensus).

Journal: Journal of asthma and allergy

Published: August 27, 2024

Clinical and serological characteristics of patients allergic to LTP.

Clinical and serological characteristics of patients allergic to LTP.

Journal: Allergologia et immunopathologia

Published: January 08, 2024

Positioning of Tezepelumab in Severe Asthma.

Positioning of Tezepelumab in Severe Asthma.

Journal: Journal of investigational allergology & clinical immunology

Published: October 09, 2023

Effectiveness of Mepolizumab in Patients with Severe Eosinophilic Asthma with/without Nasal Polyposis: A Real-Life Study.

Effectiveness of Mepolizumab in Patients with Severe Eosinophilic Asthma with/without Nasal Polyposis: A Real-Life Study.

Journal: International archives of allergy and immunology

Published: July 25, 2023

Dupilumab to induce tolerance to SLIT-Melocotón®.

Dupilumab to induce tolerance to SLIT-Melocotón®.

Journal: European annals of allergy and clinical immunology

Published: January 13, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026